查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1968734

被忽视的热带疾病诊断市场分析及预测（至2035年）：按类型、产品类型、服务、技术、应用、最终用户、设备、流程、组件划分

Neglected Tropical Diseases Diagnosis Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, End User, Device, Process, Component
出版日期: | 出版商: Global Insight Services | 英文 361 Pages | 商品交期: 3-5个工作天内

价格
简介目录

被忽视的热带疾病诊断市场预计将从2024年的67亿美元成长到2034年的120亿美元，复合年增长率约为6.6%。该市场涵盖用于识别低收入地区常被忽视的疾病（例如南美锥虫病、利什曼原虫症和血吸虫病）的诊断工具和技术。该市场专注于提供经济、快速且准确的诊断解决方案，以促进疾病的早期发现和治疗。全球卫生倡议的扩展以及研发投入的增加正在推动就地检验（POC​​T）和分子诊断技术的进步，从而满足服务不足地区对便利医疗保健解决方案的迫切需求。

被忽视的热带疾病诊断市场预计将迎来显着成长，这主要得益于诊断技术的进步和公众意识的提高。血清学检测领域预计将呈现最高的成长率，因为其准确性和快速出结果对于疾病的早期发现至关重要。分子诊断紧随其后，受益于PCR和次世代定序技术的广泛应用，这些技术能够准确识别病原体。即时诊断因其便携性和易操作性而日益普及，尤其是在偏远和资源匮乏的地区。公共和私营部门为消除被忽视的热带疾病而进行的投资进一步推动了对创新诊断解决方案的需求。免疫检测，特别是酵素连结免疫吸附试验（ELISA），仍然是诊断工具包的基础，而新生物标记的发现不断提高检测的特异性和灵敏度。研究机构、政府和医疗服务提供者之间的合作对于推动市场扩张以及确保流行地区诊断工具的可近性和可负担性至关重要。

市场区隔
类型 寄生虫病、病毒病、细菌病、真菌病、原虫病、蠕虫病、媒介传播疾病、通用感染疾病
产品 诊断试剂盒、试剂、仪器、耗材、软体、配件、检测方法、试剂盒
服务 检查服务、咨询服务、维护服务、训练服务、资料管理服务
科技 分子诊断、免疫检测诊断、层析法、质谱法、微阵列、就地检验、生物感测器
应用领域 临床诊断、研究与发展、流行病学调查、公共卫生计画、兽医诊断
最终用户 医院、诊断检查室、研究机构、学术机构、公共卫生机构、兽医诊所
装置 携带式、桌上型、穿戴式和手持式设备
过程 检体采集、检体製备、分析、数据解释和报告
成分 硬体、软体和服务

市场概况：

被忽视的热带疾病（NTD）诊断市场正经历动态变化，创新的定价策略和新产品推出推动了市场份额的成长。各公司正着力提升产品的可负担性和可近性，这对发展中地区的市场至关重要。近期产品创新提高了诊断的准确性和速度，满足了对有效解决方案的迫切需求。这些发展加剧了市场竞争，并促进了持续的进步和策略联盟。 NTD诊断市场的竞争日益激烈，主要参与者相互参照以保持市场主导地位。监管的影响至关重要，严格的指导方针确保了诊断工具的安全性和有效性。国际卫生组织的政策影响该市场，进而影响产品的开发和核准流程。新兴经济体在资金筹措和公众意识提升的支持下，正在推动市场成长。技术整合进一步优化了市场环境，有望推动诊断能力的提升和市场的扩张。

主要趋势和驱动因素：

由于公众意识的提高和全球卫生倡议的推动，被忽视的热带疾病诊断市场正在成长。各国政府和组织正在加大研发投入，以改善诊断工具。这一趋势的驱动力在于，需要对威胁弱势族群的疾病做出紧急应变。技术进步至关重要，推动了快速诊断和就地检验的创新。这些技术能够提供更快、更准确的结果，从而加强疾病管理和控制。因此，对便携式和易用型诊断设备的需求日益增长。公私合营正成为关键驱动因素，促进相关人员之间的协作。这些合作对于资金筹措和资源分配至关重要，确保诊断服务的广泛普及。此外，整合数据分析的数位健康解决方案正日益受到关注，有助于改善疾病追踪和应对。都市化加快和气候变迁加剧了疾病的传播，也对市场产生影响，为开发可扩充性、适应不同环境的诊断解决方案的公司创造了机会。

限制与挑战：

被忽视的热带疾病诊断市场目前面临许多重大限制和挑战。其中最严重的是研发资金和资源投入不足，阻碍了创新和先进诊断工具的应用。这种资金限制在这些疾病高发生的低收入地区尤为突出。另一个重大挑战是基础设施匮乏，阻碍了偏远地区诊断技术的应用和有效性。此外，缺乏训练有素的医护人员进行诊断测试和解读结果，使情况更加复杂，导致误诊和治疗无效。另外，与被忽视的热带疾病相关的文化障碍和社会污名也阻碍了人们及时寻求诊断和治疗。监管障碍也阻碍了诊断产品在全球的分销和推广，因为不同地区的标准各不相同。最后，受影响地区不稳定的政治局势扰乱了医疗卫生事业，使诊断活动的持续发展变得困难。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章 细分市场分析

  • 市场规模及预测：依类型
    • 寄生虫病
    • 病毒性疾病
    • 细菌性疾病
    • 真菌病
    • 原虫性疾病
    • 蠕虫病
    • 媒介传播疾病
    • 通用感染疾病
  • 市场规模及预测：依产品划分
    • 诊断试剂盒
    • 试剂
    • 装置
    • 消耗品
    • 软体
    • 配件
    • 侦测
    • 墨水匣
  • 市场规模及预测：依服务划分
    • 检查服务
    • 咨询服务
    • 维护服务
    • 培训服务
    • 资料管理服务
  • 市场规模及预测：依技术划分
    • 分子诊断
    • 免疫检测测定诊断
    • 层析法
    • 质谱分析
    • 微阵列
    • 即时检测
    • 生物感测器
  • 市场规模及预测：依应用领域划分
    • 临床诊断
    • 研究与开发
    • 流行病学研究
    • 公共卫生项目
    • 兽医诊断
  • 市场规模及预测：依最终用户划分
    • 医院
    • 诊断检查室
    • 研究所
    • 学术机构
    • 公共卫生机构
    • 兽医诊所
  • 市场规模及预测：依设备划分
    • 携带式装置
    • 桌面设备
    • 穿戴式装置
    • 行动装置
  • 市场规模及预测：依製程划分
    • 样本采集
    • 样品製备
    • 分析
    • 数据解读
    • 报告
  • 市场规模及预测：依组件划分
    • 硬体
    • 软体
    • 服务

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 需求与供给差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 法规概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章 公司简介

  • Chembio Diagnostics
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific
  • Meridian Bioscience
  • bioMerieux
  • Quidel Corporation
  • OraSure Technologies
  • Trinity Biotech
  • Abbott Laboratories
  • Hologic
  • QIAGEN
  • Novacyt
  • CTK Biotech
  • DiaSorin
  • GenMark Diagnostics

第九章：关于我们

简介目录
Product Code: GIS34078

Neglected Tropical Diseases Diagnosis Market is anticipated to expand from $6.7 billion in 2024 to $12.0 billion by 2034, growing at a CAGR of approximately 6.6%. The Neglected Tropical Diseases Diagnosis Market encompasses diagnostic tools and technologies designed to identify diseases often overlooked in low-income regions, such as Chagas disease, leishmaniasis, and schistosomiasis. This market focuses on affordable, rapid, and accurate diagnostic solutions to enhance early detection and treatment. Increasing global health initiatives and investments in research and development are propelling advancements in point-of-care testing and molecular diagnostics, addressing the urgent need for accessible healthcare solutions in underserved populations.

The Neglected Tropical Diseases Diagnosis Market is poised for significant growth, driven by advancements in diagnostic technologies and increasing awareness. The serological tests segment is the top-performing sub-segment, owing to its accuracy and rapid results, essential for early disease detection. Molecular diagnostics follow closely, benefiting from the rising adoption of PCR and next-generation sequencing technologies, which offer precise pathogen identification. Point-of-care diagnostics are gaining traction, especially in remote and resource-limited settings, due to their portability and ease of use. The demand for innovative diagnostic solutions is further bolstered by public and private sector investments aimed at eradicating neglected tropical diseases. Immunoassays, particularly ELISA, remain a cornerstone in the diagnostic toolkit, while novel biomarker discovery continues to enhance test specificity and sensitivity. Collaborative efforts among research institutions, governments, and healthcare providers are pivotal in driving market expansion, ensuring accessibility and affordability of diagnostic tools in endemic regions.

Market Segmentation
TypeParasitic Diseases, Viral Diseases, Bacterial Diseases, Fungal Diseases, Protozoan Diseases, Helminthic Diseases, Vector-Borne Diseases, Zoonotic Diseases
ProductDiagnostic Kits, Reagents, Instruments, Consumables, Software, Accessories, Assays, Cartridges
ServicesLaboratory Services, Consultation Services, Maintenance Services, Training Services, Data Management Services
TechnologyMolecular Diagnostics, Immunoassay Diagnostics, Chromatography, Mass Spectrometry, Microarray, Point-of-Care Testing, Biosensors
ApplicationClinical Diagnostics, Research and Development, Epidemiological Studies, Public Health Programs, Veterinary Diagnostics
End UserHospitals, Diagnostic Laboratories, Research Institutes, Academic Institutions, Public Health Organizations, Veterinary Clinics
DevicePortable Devices, Benchtop Devices, Wearable Devices, Handheld Devices
ProcessSample Collection, Sample Preparation, Analysis, Data Interpretation, Reporting
ComponentHardware, Software, Services

Market Snapshot:

The Neglected Tropical Diseases (NTD) Diagnosis Market is witnessing a dynamic shift with increasing market share driven by innovative pricing strategies and a surge in new product launches. Companies are focusing on affordability and accessibility, which is crucial for markets in developing regions. Recent product innovations are enhancing diagnostic accuracy and speed, catering to the urgent need for effective solutions. These developments are fostering a competitive landscape, encouraging continuous advancements and strategic collaborations. Competition in the NTD Diagnosis Market is intensifying, with key players benchmarking against each other to maintain market dominance. Regulatory influences are pivotal, as stringent guidelines ensure the safety and efficacy of diagnostic tools. The market is shaped by policies from global health organizations, influencing product development and approval processes. Emerging economies are contributing to market growth, supported by increased funding and awareness. The landscape is further enriched by technological integration, promising enhanced diagnostic capabilities and market expansion.

Geographical Overview:

The Neglected Tropical Diseases (NTD) Diagnosis Market is expanding across diverse regions, each with unique growth dynamics. Africa remains a focal point, driven by a high prevalence of NTDs and increased governmental and non-governmental interventions. Efforts to improve healthcare infrastructure and diagnostic capabilities are bolstering market growth. In Asia Pacific, countries like India and Indonesia are witnessing rapid advancements due to significant investments in healthcare and diagnostic technologies. This region's large population and rising healthcare awareness contribute to its market expansion. Latin America, particularly Brazil, is emerging as a promising market, with increased public health initiatives and government support for NTD diagnosis. The Middle East is also gaining traction, with countries like Saudi Arabia and the UAE investing in healthcare innovations to combat NTDs. These emerging markets present lucrative opportunities for stakeholders aiming to address the global NTD burden through improved diagnostic solutions.

Key Trends and Drivers:

The Neglected Tropical Diseases Diagnosis Market is experiencing growth due to increased awareness and global health initiatives. Governments and organizations are investing in research and development to improve diagnostic tools. This trend is driven by the urgent need to address diseases affecting vulnerable populations. Technological advancements are pivotal, with innovations in rapid diagnostics and point-of-care testing. These technologies offer quicker, more accurate results, enhancing disease management and control. As a result, there is a growing demand for portable and easy-to-use diagnostic devices. Public-private partnerships are emerging as a key driver, fostering collaboration between stakeholders. These alliances are crucial for funding and resource allocation, ensuring widespread access to diagnostics. Additionally, digital health solutions are gaining traction, integrating data analytics to improve disease tracking and response. The market is also influenced by increasing urbanization and climate change, which exacerbate disease spread. This creates opportunities for companies to develop adaptable and scalable diagnostic solutions tailored to diverse environments.

Restraints and Challenges:

The Neglected Tropical Diseases Diagnosis Market is currently grappling with several critical restraints and challenges. Foremost among these is the limited funding and resource allocation for research and development, which stifles innovation and the introduction of advanced diagnostic tools. This financial constraint is particularly pronounced in low-income regions where these diseases are most prevalent. Another significant challenge is the lack of infrastructure, which hampers the deployment and effectiveness of diagnostic technologies in remote areas. Moreover, the scarcity of trained healthcare professionals to administer and interpret diagnostic tests further complicates the situation, leading to misdiagnoses and ineffective treatment. Additionally, cultural barriers and stigma associated with neglected tropical diseases dissuade individuals from seeking timely diagnosis and care. Regulatory hurdles also pose a challenge, as varying standards across regions impede the global distribution and acceptance of diagnostic products. Lastly, the volatile political environments in affected regions can disrupt healthcare initiatives, making it difficult to sustain diagnostic efforts.

Key Players:

Chembio Diagnostics, Bio-Rad Laboratories, Thermo Fisher Scientific, Meridian Bioscience, bioMerieux, Quidel Corporation, OraSure Technologies, Trinity Biotech, Abbott Laboratories, Hologic, QIAGEN, Novacyt, CTK Biotech, DiaSorin, GenMark Diagnostics

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Device
  • 2.8 Key Market Highlights by Process
  • 2.9 Key Market Highlights by Component

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Parasitic Diseases
    • 4.1.2 Viral Diseases
    • 4.1.3 Bacterial Diseases
    • 4.1.4 Fungal Diseases
    • 4.1.5 Protozoan Diseases
    • 4.1.6 Helminthic Diseases
    • 4.1.7 Vector-Borne Diseases
    • 4.1.8 Zoonotic Diseases
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Diagnostic Kits
    • 4.2.2 Reagents
    • 4.2.3 Instruments
    • 4.2.4 Consumables
    • 4.2.5 Software
    • 4.2.6 Accessories
    • 4.2.7 Assays
    • 4.2.8 Cartridges
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Laboratory Services
    • 4.3.2 Consultation Services
    • 4.3.3 Maintenance Services
    • 4.3.4 Training Services
    • 4.3.5 Data Management Services
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Molecular Diagnostics
    • 4.4.2 Immunoassay Diagnostics
    • 4.4.3 Chromatography
    • 4.4.4 Mass Spectrometry
    • 4.4.5 Microarray
    • 4.4.6 Point-of-Care Testing
    • 4.4.7 Biosensors
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Clinical Diagnostics
    • 4.5.2 Research and Development
    • 4.5.3 Epidemiological Studies
    • 4.5.4 Public Health Programs
    • 4.5.5 Veterinary Diagnostics
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Hospitals
    • 4.6.2 Diagnostic Laboratories
    • 4.6.3 Research Institutes
    • 4.6.4 Academic Institutions
    • 4.6.5 Public Health Organizations
    • 4.6.6 Veterinary Clinics
  • 4.7 Market Size & Forecast by Device (2020-2035)
    • 4.7.1 Portable Devices
    • 4.7.2 Benchtop Devices
    • 4.7.3 Wearable Devices
    • 4.7.4 Handheld Devices
  • 4.8 Market Size & Forecast by Process (2020-2035)
    • 4.8.1 Sample Collection
    • 4.8.2 Sample Preparation
    • 4.8.3 Analysis
    • 4.8.4 Data Interpretation
    • 4.8.5 Reporting
  • 4.9 Market Size & Forecast by Component (2020-2035)
    • 4.9.1 Hardware
    • 4.9.2 Software
    • 4.9.3 Services

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Device
      • 5.2.1.8 Process
      • 5.2.1.9 Component
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Device
      • 5.2.2.8 Process
      • 5.2.2.9 Component
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Device
      • 5.2.3.8 Process
      • 5.2.3.9 Component
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Device
      • 5.3.1.8 Process
      • 5.3.1.9 Component
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Device
      • 5.3.2.8 Process
      • 5.3.2.9 Component
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Device
      • 5.3.3.8 Process
      • 5.3.3.9 Component
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Device
      • 5.4.1.8 Process
      • 5.4.1.9 Component
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Device
      • 5.4.2.8 Process
      • 5.4.2.9 Component
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Device
      • 5.4.3.8 Process
      • 5.4.3.9 Component
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Device
      • 5.4.4.8 Process
      • 5.4.4.9 Component
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Device
      • 5.4.5.8 Process
      • 5.4.5.9 Component
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Device
      • 5.4.6.8 Process
      • 5.4.6.9 Component
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Device
      • 5.4.7.8 Process
      • 5.4.7.9 Component
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Device
      • 5.5.1.8 Process
      • 5.5.1.9 Component
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Device
      • 5.5.2.8 Process
      • 5.5.2.9 Component
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Device
      • 5.5.3.8 Process
      • 5.5.3.9 Component
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Device
      • 5.5.4.8 Process
      • 5.5.4.9 Component
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Device
      • 5.5.5.8 Process
      • 5.5.5.9 Component
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Device
      • 5.5.6.8 Process
      • 5.5.6.9 Component
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Device
      • 5.6.1.8 Process
      • 5.6.1.9 Component
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Device
      • 5.6.2.8 Process
      • 5.6.2.9 Component
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Device
      • 5.6.3.8 Process
      • 5.6.3.9 Component
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Device
      • 5.6.4.8 Process
      • 5.6.4.9 Component
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Device
      • 5.6.5.8 Process
      • 5.6.5.9 Component

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Chembio Diagnostics
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Bio-Rad Laboratories
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Thermo Fisher Scientific
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Meridian Bioscience
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 bioMerieux
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Quidel Corporation
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 OraSure Technologies
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Trinity Biotech
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Abbott Laboratories
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Hologic
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 QIAGEN
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Novacyt
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 CTK Biotech
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 DiaSorin
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 GenMark Diagnostics
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us